Now comes the ethical question: Can we ever go back?
"Do we go back to business as usual, or were there elements that were coming into play during the time of corona that could help accelerate the vaccine pipeline?" asked Stanford immunology professor Bali Pulendran, Ph.D.
RELATED: CDC officially allows Pfizer's COVID-19 vaccine to be administered in US
Pulendran believes the answer could have profound implications for the business of vaccines. First, it helps to understand how a development process that can normally take up to a decade was compressed into months. Fueling the launch was a set of emergency laws enacted after the post 9/11 anthrax attacks, designed to combat bio-terrorism by developing emergency vaccines. Applied to the COVID-19 crisis, they opened up a massive funding pipeline guaranteeing drug makers a pre-paid market, and allowing them to jump-start development.
"So that companies could make them, even before they knew how safe or effective they were," explained Pulendran.
VIDEO: Bay Area counties on stand-by to receive 1st batch of Pfizer COVID-19 vaccine
The pandemic also unleashed a new level of coordinated planning for everything from distributing vaccines nationwide to figuring out how to administer them to patients, underscoring social issues like fairness and cost.
"There's nothing like a pandemic which, by its definition, does not discriminate at all, I mean everyone is vulnerable," says fellow Stanford professor Dr. David Relman, M.D.
Dr. Relman is also a professor of immunology at Stanford. He believes the need to vaccinate a majority of Americans against COVID-19 and possible future viral outbreaks could spark a fresh look at access to health care. The government has pledged to initially make COVID vaccines available for little or no cost. Still, projected profits from some of the early vaccines are estimated to reach the billions of dollars as time goes on. And drug companies will also hold lucrative patents for years to come, with future costs uncertain.
RELATED: 'Breathtaking': UCSF doctor explains impact of CA receiving 327,000 doses of Pfizer vaccine
"There are so many aspects of this pandemic that have brought to light the fundamental reasons why we have a public health system," says Dr. Relman.
With thousands of lives in the balance, some believe there could be growing pressure to re-examine the government's long term role in speeding vaccine development, spear heading distribution and keeping costs to patients under control.
"I think this is a big issue, we have to take a cold hard look at the way we make vaccines," said Pulendran.
If you have a question or comment about the coronavirus pandemic, submit yours via the form below or here.
Get the latest news, information and videos about the novel coronavirus pandemic here
RELATED STORIES & VIDEOS:
- Map: CA counties that can, can't reopen under new rules
- COVID-19 risk calculator: The safest and most dangerous things to do this holiday season
- Want to get a COVID-19 test in time for the holidays? Here's what you need to know
- Updated number of COVID-19 deaths, cases in Bay Area
- Map shows everywhere you can get a COVID-19 test in the Bay Area
- COVID-19 Diaries: Personal stories of Bay Area residents during pandemic
- California EDD: The most commonly asked questions we get about unemployment and PUA
- Health experts urge flu shots in effort to avoid 'twindemic'
- How to tell the difference between seasonal allergies and coronavirus symptoms
- Here's which mask is better to protect from COVID-19
- First COVID-19 vaccine volunteers in US describe experience as Bay Area launches vaccine trials
- Coronavirus origin: Where did COVID-19 come from?
- What is a COVID-19 genetic, antigen and antibody test?
- What will it take to get a COVID-19 vaccine and how will it be made?
- What does COVID-19 do to your body and why does it spread so easily?
- Here's how shelter in place, stay at home orders can slow spread of COVID-19
- Coronavirus Timeline: Tracking major moments of COVID-19 pandemic in San Francisco Bay Area
- Coronavirus Doctor's Note: Dr. Alok Patel gives his insight into COVID-19 pandemic